Addex Pharmaceuticals 2007 Financial Results

Addex Achieves First Milestone in Parkinson’s Disease Collaboration with Merck & Co., Inc.

Addex and Merck & Co., Inc. Enter License Agreement to Develop a Drug Candidate for Schizophrenia

Addex Announces ADX10059 Phase IIa Acute Anxiety Data

Addex and Merck & Co. Collaborate to Develop Drugs for Parkinson’s Disease

Addex Pharmaceuticals Confirms Extension of Major Shareholder Lock-up

Addex Presents ADX10059 GERD Data at Conference

ADX10061 Smoking Cessation Data

Addex Pharmaceuticals appoints Head of ADME/PK

Addex Pharmaceuticals First Half 2007 Financial Results